Back
Spyre Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
SYRE
Spyre Therapeutics
Last Price:
27.68
Seasonality Move:
-1.09%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Spyre Therapeutics Price Quote
$27.68
-0.02 (2.52%)
(Updated: November 23, 2024 at 3:15 AM ET)
Spyre Therapeutics Key Stats
Sell
44
Spyre Therapeutics (SYRE)
is a Sell
Day range:
$26.73 - $28.01
52-week range:
$10.42 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
951.77
P/B ratio:
9.48%
Volume:
781.5K
Avg. volume:
616K
1-year change:
166.6%
Market cap:
$1.6B
Revenue:
$886K
EPS:
$-4.12
How Much Does Spyre Therapeutics Make?
Data Unavailable
Is Spyre Therapeutics Growing As A Company?
Data Unavailable
Spyre Therapeutics Stock Price Performance
-
Did Spyre Therapeutics Stock Go Up Last Month?
Spyre Therapeutics share price went down by -18.89% last month -
Did SYRE's Share Price Rise Over The Last Year?
SYRE share price rose by 166.6% over the past 1 year
What Is Spyre Therapeutics 52-Week High & Low?
-
What Is Spyre Therapeutics’s 52-Week High Share Price?
Spyre Therapeutics has traded as high as $47.97 over the past 52 weeks -
What Is Spyre Therapeutics’s 52-Week Low Share Price?
Spyre Therapeutics has traded as low as $10.42 over the past 52 weeks
Spyre Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Spyre Therapeutics?
-
How Much Debt Does Spyre Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Spyre Therapeutics Have?
Cash and short term investments quarterly total is $414.2M -
What Is Spyre Therapeutics’s Book Value Per Share?
Book value per share is 3.34
Is Spyre Therapeutics Cash Flow Positive?
-
What Is SYRE Cash Flow From Operations?
Cash flow from operations (TTM) is -$151.2M -
What Is Spyre Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $348.9M -
What Is Spyre Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$218M
Spyre Therapeutics Return On Invested Capital
Data Unavailable
Spyre Therapeutics Earnings Date & Stock Price
-
What Is Spyre Therapeutics's Stock Price Today?
A single share of SYRE can be purchased today for 27.70 -
What Is Spyre Therapeutics’s Stock Symbol?
Spyre Therapeutics trades on the nasdaq under the ticker symbol: SYRE -
When Is Spyre Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Spyre Therapeutics is scheduled on February 28, 2025 -
When Is SYRE's next ex-dividend date?
Spyre Therapeutics's next ex-dividend date is November 23, 2024 -
How To Buy Spyre Therapeutics Stock?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Spyre Therapeutics Competitors
-
Who Are Spyre Therapeutics's Competitors?
Below is a list of companies who compete with Spyre Therapeutics or are related in some way:
Spyre Therapeutics Dividend Yield
-
What Is SYRE Dividend Yield?
Spyre Therapeutics’s dividend yield currently is 0% -
What Is Spyre Therapeutics’s Payout Ratio?
Spyre Therapeutics’s payout ratio is 0% -
When Did Spyre Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Spyre Therapeutics’s Dividend Per Share?
Spyre Therapeutics pays a dividend of $0.00 per share
Spyre Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -57.77% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 58.63 |
| Upside from Last Price: | 111.64% |